Back to results
US 2026/0248956 A1Published application
Adeno-associated virus pharmaceutical composition and use thereof
AssigneeChengdu Origen Biotechnology Co., Ltd.
InventorsXiao KE, Qiang ZHENG, Hao JIANG, Yingfei QIN, Junbo LUO
Life of this patent
Estimating the term…
Abstract
Provided is a pharmaceutical composition, the pharmaceutical composition containing a recombinant adeno-associated virus (AAV), a buffer solution, an amino acid, a stabilizer, and a nonionic surfactant. The pharmaceutical composition has good stability.
Claims30
1-29. (canceled)
A pharmaceutical composition characterized in that the pharmaceutical composition comprises a recombinant adeno-associated virus and a buffer, an amino acid, a stabilizer, a nonionic surfactant, with the buffer being a citrate buffer.
Dependencies are inferred from the claim text.